PIP4K and the role of nuclear phosphoinositides in tumour suppression.

Abstract

Phosphatidylinositol-5-phosphate (PtdIns5P)-4-kinases (PIP4Ks) are stress-regulated lipid kinases that phosphorylate PtdIns5P to generate PtdIns(4,5)P₂. There are three isoforms of PIP4Ks: PIP4K2A, 2B and 2C, which localise to different subcellular compartments with the PIP4K2B isoform being localised predominantly in the nucleus. Suppression of PIP4K expression selectively prevents tumour cell growth in vitro and prevents tumour development in mice that have lost the tumour suppressor p53. p53 is lost or mutated in over 70% of all human tumours. These studies suggest that inhibition of PIP4K signalling constitutes a novel anti-cancer therapeutic target. In this review we will discuss the role of PIP4K in tumour suppression and speculate on how PIP4K modulates nuclear phosphoinositides (PPIns) and how this might impact on nuclear functions to regulate cell growth. This article is part of a Special Issue entitled Phosphoinositides.

DOI: 10.1016/j.bbalip.2015.02.014

Cite this paper

@article{Fiume2015PIP4KAT, title={PIP4K and the role of nuclear phosphoinositides in tumour suppression.}, author={Roberta Fiume and Yvette Stijf-Bultsma and Zahid H. Shah and Willem jan Keune and David R. Jones and Julian Jude and Nullin Divecha}, journal={Biochimica et biophysica acta}, year={2015}, volume={1851 6}, pages={898-910} }